PATIENT ENGAGEMENT

Patient Organization

The patient comes first

For Bayer, one of the world's leading specialty pharmaceutical companies, patients' health always comes first. Exchanging ideas and information with patient organizations on the basis of mutual trust is an important component of our work.

 

Such cooperation helps us to understand the needs of patients as they come to terms with their illness. This enables us to gear our research and development to these needs and to continue working on improved, new drugs and therapies.

 

Bayer cooperates with patient organizations in all kinds of therapeutic areas. We attach great importance to transparency in this context and protect the independence of our cooperation partners.

 

Our principles

Cooperation between Bayer and patient organizations is based on the following principles.

  1. In order to provide patients with quality medical healthcare, a partnership with a patient organization pursues a specific objective concentrating on one or more of the following areas:
    • raising awareness for certain diseases by improving diagnostic possibilities and preventive measures, knowing the patients' prospects and needs,
    • understanding diseases and making sure that patients receive the best medical treatment available,
    • improving the information provided to the patients,
    • supporting medical innovations.
  2. Bayer and the patient organizations comply with international and national laws and regulations.
  3. Cooperation with a patient organization should neither influence decisions on a therapy nor promote or support specific therapies.
  4. Bayer respects the neutrality and independence of patient organizations. Cooperation is based on a partnership between equals in which transparency and clarity are fundamental principles. This is why we also provide information on the extent and nature of support.

 

Overview of cooperation with patient organizations in Europe in 2021

The following is a list of patient organizations with which Bayer and its affiliated companies in Europe cooperated in 2021.

 

Headquarters:

Bayer Company

Bayer AG

Contract date

2021

Amount

50.000 EUR

Purpose of interaction

Supporting the development and implementation of national stroke plans through the Stroke Action Plan for Europe (SAPE)

 

Bayer Company

Bayer AG

Contract date

28.09.2021

Amount

10.000 EUR

Purpose of interaction

Bronze membership in organization to attend conference and have logo on website; Access to Patient Advisory Network for study-related survey

 

Bayer Company

Bayer AG

Contract date

6/2021

Amount

15.000 EUR

Purpose of interaction

One year Diamond membership for Patient engagement activities

 

Bayer Company

Bayer AG

Contract date

6/2021

Amount

1.890 EUR

Purpose of interaction

Patient recruitment for podcast series  regarding regenerative medicine discussions

 

Bayer Company

Bayer AG

Contract date

12/2021

Amount

46.480 EUR

Purpose of interaction

Four Patient Engagement symposiums, resource + manual 

Bayer Company

Bayer AG

Contract date

15.06.2020

Amount

25.000 EUR

Purpose of interaction

World Scleroderma Day Sponsorship

 

Bayer Company

Bayer AG

Contract date

03.07.2021

Amount

75.000 EUR

Purpose of interaction

Sponsorship of Activities of PHA Europe

 

Bayer Company

BCC AG

Contract date

24.09.2021

Amount

40.000 EUR

Purpose of interaction

Annual Sponsorship

 

Bayer Company

BCC AG

Contract date

27.01.2021

Amount

5.000 GBP

Purpose of
interaction

Annual Sponsorship

 

Bayer Company

BCC AG

Contract date

26.05.2021

Amount

35.000 EUR

Purpose of interaction

Sponsorship Agreement EHC 2021 Annual Conference

 

Bayer Company

BCC AG

Contract date

25.02.2021

Amount

30.000 EUR

Purpose of interaction

Platinum CGP membership

Bayer Company

BCC AG

Contract date

01.03.2021

Amount

598,50 EUR

Purpose of interaction

EU Patient Council / honorarium

 

 

Europe:

Reports can be received from

UAB Bayer Baltic Republics (Estonia, Latvia, Lithuania) 
Alina Tikuišiene MD
Zirmunu str. 68A 
LT-09124 Vilnius/Lithunia
 

Reports can be received from    

UAB Bayer Baltic Republics (Estonia, Latvia, Lithuania) 
Alina Tikuišiene MD
Zirmunu str. 68A 
LT-09124 Vilnius/Lithunia
 

Reports can be received from    

Bayer AB- Bayer Scandinavia
Iina Wargh
Gustav III:s Boulevard 56
169 26 Solna

Reports can be received from    

SC Bayer SRL 
Bayer Pharmaceuticals Division 
Sos. Pipera nr. 42., Sector 2 
NUSCO Tower fl. 1,16,17 
020112, Bucharest
Romania

Reports can be received from    

Bayer Pharma d.o.o. 
Jelena Tokanovic
Omladinskih brigada 88b
Belgrade

Reports can be received from    

Bayer d.o.o. 
Lucija Zlodi Gosnik
Bravnicarjeva 13
1000 Ljubljana